Sarpogrelate hydrochloride
SIGMA/S5451 - ≥98% (HPLC)
Synonym: Anplag; Butanedioic acid 1-
CAS Number: 135159-51-2
Empirical Formula (Hill Notation): C24H31NO6.HCl
Molecular Weight: 465.97
MDL Number: MFCD00887582
Linear Formula: C24H31NO6.HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | solid |
| InChI | 1S/C24H31NO6.ClH/c1-25(2) |
| InChI key | POQBIDFFYCYHOB-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.COc1cccc(CCc2ccccc2OCC |
| solubility | deionized water: ≥5 mg/mL |
| storage condition | desiccated |
| storage temp. | room temp |
| Biochem/physiol Actions: | Sarapogrelate hydrochloride is a potent and selective 5-HT2A receptor antagonist. |
| Biochem/physiol Actions: | Sarapogrelate hydrochloride is a potent and selective 5-HT2A receptor antagonist. It exhibits analgesic effects in numerous animal studies. |
| General description: | Sarpogrelate hydrochloride binds to the serotonin receptor (5-hydroxytryptamine, 5-HT2A). Its binding to 5-HT2A receptor inhibits thrombus formation and reduces platelet aggregation. Sarpogrelate hydrochloride has been used as an anti-atherosclerotic agent. It improves the endothelial function and may be useful for treating peripheral arterial disease. Use of sarpogrelate hydrochloride as 5-HT2A antagonist reduces urinary albumin levels in diabetic nephropathy. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302 - H400 |
| Precautionary statements | P273 |
| Hazard Codes | Xn,N |
| Risk Statements | 22-50/53 |
| Safety Statements | 60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |



